An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. [electronic resource]
Producer: 20171108Description: 2823-2832 p. digitalISSN:- 1433-7339
- Bone Density Conservation Agents -- administration & dosage
- Bone Neoplasms -- drug therapy
- Denosumab -- administration & dosage
- Diphosphonates -- administration & dosage
- Europe
- Female
- Humans
- Imidazoles -- administration & dosage
- Infusions, Intravenous
- Injections, Subcutaneous
- Male
- Time and Motion Studies
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.